Differences

This shows you the differences between two versions of the page.

--- covid-19:treatments:drug_therapies:hydroxychloroquine [2022/01/14 03:51]
mathew added Vincent paper
+++ covid-19:treatments:drug_therapies:hydroxychloroquine [2022/10/05 01:02] (current)
mathew
@@ Line 14: / Line 14: @@
   * In 2005, researcher Martin Vincent and colleagues noted that chloroquine is a potent inhibitor of SARS coronavirus infection and spread.((August 22, 2005 | Vincent et al | [[:Virology Journal]] | [[https://virologyj.biomedcentral.com/articles/10.1186/1743-422X-2-69|doi: 10.1186/1743-422X-2-69]]))
-==== Antiviral Properties Research ====
+==== Antiviral Properties Research (Mechanisms) ====
+  * Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture((September 14, 2022 | Zixuan Yuan et al | Nature (journal) | Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture | [[https://www.nature.com/articles/s42003-022-03841-8|doi.org/10.1038/s42003-022-03841-8]]))
 ===== Evidence for Prophylaxis =====